United States Drug Manufacturers - General news

15:11 26 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Mira Pharmaceuticals Inc (MIRA) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides an overview of Mira Pharmaceuticals Inc (MIRA) dividends and stock splits, noting that no dividend data is available and zero dividends have been distributed in the past five years. It also includes current stock information, showing MIRA trading at $0.882 with …

MIRA main company

Sharemaestro market context Price below Trend Line 52 weeks -45.4%

12:38 26 Jul 2026

AD HOC NEWS Earnings Main company 🇺🇸 United States

Merck stock trades steadily as oncology revenue supports earnings outlook

Merck & Co. Inc.'s stock performance is heavily influenced by its oncology division, particularly the Keytruda franchise, which has consistently delivered strong revenue growth. This growth helps offset other pharmaceutical segments' competitive pressures and patent expirations, providing a stable earnings outlook for investors. The …

MRK main company

Sharemaestro market context Trend signal active 52 weeks +60.7%

12:31 26 Jul 2026

Simply Wall Street Earnings Main company 🇺🇸 United States

Amgen (AMGN) Beat Revenue Forecasts, Is The Stock Overvalued?

Amgen (AMGN) exceeded revenue forecasts with $8.62 billion, driven by double-digit growth across 16 brands, leading to positive investor response and significant share price returns. While a narrative suggests the stock is 4.5% overvalued at $376.04 compared to a fair value of $359.98, a …

AMGN main company

Sharemaestro market context Trend signal active 52 weeks +44.4%

11:48 26 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Amgen Inc. $AMGN Shares Purchased by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp has increased its stake in Amgen Inc. by 23.1% in the first quarter, purchasing an additional 7,765 shares to bring its total holdings to 41,398 shares valued at approximately $14.6 million. This move is part of broader institutional ownership, with hedge …

AMGN main company

Sharemaestro market context Trend signal active 52 weeks +44.4%

10:49 26 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Amgen Inc. $AMGN Shares Sold by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund reduced its stake in Amgen Inc. (NASDAQ:AMGN) by 53.4% in the first quarter, selling over 200,000 shares. Despite this, several other institutional investors increased their holdings, and institutions collectively own 76.50% of the company's stock. Amgen recently …

AMGN main company

Sharemaestro market context Trend signal active 52 weeks +44.4%

09:50 26 Jul 2026

MarketBeat Analyst action Main company 🇺🇸 United States

Entropy Technologies LP Buys Shares of 9,161 Amgen Inc. $AMGN

Entropy Technologies LP has acquired a new stake of 9,161 shares in Amgen Inc. (NASDAQ:AMGN), valued at approximately $3.223 million. Other institutional investors like Vanguard Group Inc. and State Street Corp have also increased their holdings in Amgen. Analyst ratings for Amgen are diversified, …

AMGN main company

Sharemaestro market context Trend signal active 52 weeks +44.4%

09:13 26 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Gabelli Funds LLC Reduces Stake in Amgen Inc. $AMGN

Gabelli Funds LLC decreased its stake in Amgen Inc. by 4.6% in the first quarter of 2026, selling 2,735 shares and holding 57,165 shares valued at approximately $20.1 million. Despite this reduction, Amgen reported strong Q1 earnings, surpassing analyst expectations with an EPS of …

AMGN main company

Sharemaestro market context Trend signal active 52 weeks +44.4%

08:29 26 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Aristotle Atlantic Partners LLC Purchases Shares of 4,000 Amgen Inc. $AMGN

Aristotle Atlantic Partners LLC acquired a new position of 4,000 shares in Amgen Inc. (NASDAQ:AMGN) during the first quarter, valued at approximately $1.4 million. Other institutional investors like Brighton Jones LLC, Sivia Capital Partners LLC, Schnieders Capital Management LLC, Main Street Financial Solutions LLC, …

AMGN main company

Sharemaestro market context Trend signal active 52 weeks +44.4%

07:41 26 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Scilex Holding Co (SCLX) Income Statement

This article provides a detailed quarterly and annual income statement for Scilex Holding Co (SCLX), offering insights into its financial performance and operational efficiency. It presents key financial metrics such as total revenue, cost of revenue, operating expenses, operating profit, net income, and basic/diluted …

SCLX main company

Sharemaestro market context Trend signal active 52 weeks -42.5% · Next-week setup negative 43.9%

04:21 26 Jul 2026

Business Chief Market update Main company 🇺🇸 United States

Sanofi Announces Executive Leadership Reshuffle

Sanofi has announced a significant reshuffle of its Executive Committee, integrating senior figures from across its commercial, research, and global divisions to support its next phase of growth starting September 1, 2026. Belén Garijo, CEO, emphasized that the updated leadership team will focus on …

SNY main company

Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup positive 56.1%

03:35 26 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Scilex Holding Co (SCLX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Scilex Holding Co (SCLX), noting that no earnings forecast score is currently available, while the Pharmaceuticals industry average is 7.86. One analyst has a "Hold" rating for SCLX with a target price of $490.00, suggesting a significant …

SCLX main company

Sharemaestro market context Trend signal active 52 weeks -42.5% · Next-week setup negative 43.9%

03:12 26 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

AZN|AstraZeneca PLC|Price:169.260|Chg%:+0.720

AstraZeneca PLC's stock (AZN) closed at $169.260, up 0.43% on July 24th, with a market capitalization of $525.04B. Despite recent market underperformance, the company boasts healthy fundamentals, high growth potential, and significant institutional ownership. Analysts maintain a "Buy" rating with a target price indicating …

AZN main company

Sharemaestro market context Price below Trend Line 52 weeks -1.4%

02:38 26 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Merck & Co., Inc. $MRK Shares Sold by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 1.3% in the first quarter, selling 9,359 shares. Despite this, Merck reported strong quarterly earnings, beating analyst expectations, and reaffirmed its long-term guidance. The company also declared a quarterly dividend …

MRK main company

Sharemaestro market context Trend signal active 52 weeks +60.7%

23:39 25 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Grifols SA (GRFS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Grifols SA (GRFS), identifying its major institutional investors and their holdings. Key shareholders include Brandes Investment Partners, Capital World Investors, and Permian Investment Partners. The report also provides a breakdown of shareholder types and a history of …

GRFS main company

Sharemaestro market context Price below Trend Line 52 weeks -23.4%

23:38 25 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

SRB Corp Reduces Holdings in Merck & Co., Inc. $MRK

SRB Corp reduced its stake in Merck & Co., Inc. by 2.1% in the first quarter, selling 10,067 shares, though Merck remains its 15th largest holding. Despite this trimming, Wall Street analysts maintain a "Moderate Buy" rating with an average target price of $133.94, …

MRK main company

Sharemaestro market context Trend signal active 52 weeks +60.7%

22:38 25 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Healthcare of Ontario Pension Plan Trust Fund Cuts Stake in Merck & Co., Inc. $MRK

Healthcare of Ontario Pension Plan Trust Fund reduced its stake in Merck & Co., Inc. by 10.2% in the first quarter, selling 95,504 shares. Despite this reduction, Merck's recent quarterly earnings surpassed expectations with revenue up 4.9% year-over-year and reaffirmed its FY 2026 EPS …

MRK main company

Sharemaestro market context Trend signal active 52 weeks +60.7%

22:12 25 Jul 2026

The National Law Review Regulatory and legal Main company 🇺🇸 United States

Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. (NYSE:OGN). The investigation focuses on whether Organon and its officers engaged in corporate wrongdoing, specifically for investors who purchased Organon securities before November 3, 2022, and continue …

OGN main company

Sharemaestro market context Trend signal active 52 weeks +46.5%

21:08 25 Jul 2026

Yahoo! Finance Canada Earnings Main company 🇺🇸 United States

Merck & Co., Inc. (MRK) Stock Price, News, Quote & History

This article provides a comprehensive overview of Merck & Co., Inc. (MRK), including its current stock price, historical performance, key financial metrics, and product portfolio. It details the company's operations as a global healthcare provider, highlighting its pharmaceutical and veterinary products, as well as …

MRK main company

Sharemaestro market context Trend signal active 52 weeks +60.7%

20:41 25 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Scilex Holding Company Revenue Breakdown – NASDAQ:SCLXW

This article provides a revenue breakdown for Scilex Holding Company (NASDAQ: SCLXW), highlighting its financial performance. The primary revenue contribution for the company in recent years has come from the United States, with figures of $30.25 million last year and $56.59 million the year …

SCLX main company

Sharemaestro market context Trend signal active 52 weeks -42.5% · Next-week setup negative 43.9%

20:37 25 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Bristol-Myers Squibb Company Revenue Breakdown – HAM:BRM

Bristol-Myers Squibb Company (HAM:BRM) generated €41.03 billion in revenue last year, primarily from its Innovative Medicines segment. This marks a decrease from the previous year's €46.66 billion. The United States was the largest contributor to revenue, accounting for €28.33 billion.

BMY main company

Sharemaestro market context Trend signal active 52 weeks +38.1%

19:40 25 Jul 2026

ACCESS Newswire Market update Main company 🇺🇸 United States

Bronstein, Gewirtz & Grossman, LLC Is Investigating AstraZeneca PLC (AZN) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AstraZeneca PLC (AZN) after the company announced its Phase-3 CARDIO-TTransform trial for Wainua failed to meet its primary endpoint. This news led to a 5.7% drop in AstraZeneca's American Depositary …

AZN main company

Sharemaestro market context Price below Trend Line 52 weeks -1.4%

19:10 25 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

MIRA Pharmaceuticals, Inc. Revenue Breakdown – LSX:A3EQWL

The article provides a financial overview of MIRA Pharmaceuticals, Inc. (A3EQWL) on the Lang & Schwarz Exchange, detailing available fundamental and statistical data such as overview, statements, statistics, dividends, earnings, and segments. It specifically highlights the company's revenue breakdown by source and country. The …

MIRA main company

Sharemaestro market context Price below Trend Line 52 weeks -45.4%

17:09 25 Jul 2026

Market source Earnings Main company 🇺🇸 United States

AbbVie (ABBV) Could Be 3% Undervalued Following Epcoritamab Trial Setback

AbbVie (ABBV) may be 3% undervalued despite a recent setback in the Phase 3 EPCORE DLBCL-1 trial for its drug epcoritamab. The company's diverse pipeline and strong cash generation suggest potential for future growth, with a fair value estimated at $266.89 against a last …

ABBV main company

Sharemaestro market context Trend signal active 52 weeks +21.3% · Next-week setup positive 57.6%

16:08 25 Jul 2026

Seeking Alpha Market update Main company 🇺🇸 United States

Insider trades: Johnson & Johnson, TSMC among notable names (AA:NYSE)

This article highlights recent insider trading activities from July 20 to July 24, 2026. Notable transactions include a sale of 23,054 shares by Johnson & Johnson's Executive Vice President Vanessa Broadhurst. Other companies mentioned in the context of insider trades are Snap and TSMC.

JNJ main company

Sharemaestro market context Trend signal active 52 weeks +48.8%

15:12 25 Jul 2026

The Robot Report Market update Main company 🇺🇸 United States

Photos: First look at J&J’s Ottava surgical robot

Johnson & Johnson MedTech has unveiled its Ottava surgical robot, which recently received FDA de novo authorization. This system is the world's first table-integrated, soft-tissue robotics platform, designed to save space in operating rooms by having its four robotic arms emerge from underneath the …

JNJ main company

Sharemaestro market context Trend signal active 52 weeks +48.8%

14:40 25 Jul 2026

Barron's Market update Main company 🇺🇸 United States

Eli Lilly and Novo Nordisk Are Locked in a Legal War. Don’t Lose Sight of the Main Event.

Eli Lilly and Novo Nordisk are currently engaged in a legal dispute, but the financial community is more focused on a larger underlying narrative. Eli Lilly is expected to seek regulatory approval for its drug retatrutide in the first quarter of 2027.

LLY main company NVO main company

Sharemaestro market context Trend signal active 52 weeks +66.6% · Next-week setup positive 58.3%

14:40 25 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Novartis AG Revenue Breakdown – BX:NOT

Novartis AG's latest financial data shows a total revenue of 43.23 billion CHF. The Oncology segment was the top performer, contributing 13.98 billion CHF, an increase from 12.98 billion CHF in the previous year. The United States was the largest regional contributor, accounting for …

NVS main company

Sharemaestro market context Trend signal active 52 weeks +22.5% · Next-week setup positive 61.2%

14:12 25 Jul 2026

TipRanks Earnings Main company 🇺🇸 United States

Organon & Co. (1OGN) Q4 2025 Earnings Report - Results, Call & Slides

Organon & Co. reported Q4 2025 earnings, missing both EPS and revenue expectations with actual EPS of €0.55 against consensus €0.64 and actual revenue of €1.32 billion against an expected €1.35 billion. The company provided a neutral outlook, guiding for roughly flat revenue and …

OGN main company

Sharemaestro market context Trend signal active 52 weeks +46.5%

13:42 25 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Novartis AG ADR Cert Deposito Arg Repr 0.25 ADRs Revenue Breakdown – BCBA:NVSB

Novartis AG (BCBA:NVSB) generated significant revenue last year, reaching 79.15 trillion ARS. The Oncology segment was the top performer, contributing 25.59 trillion ARS, and the United States was the largest regional contributor with 35.47 trillion ARS.

NVS main company

Sharemaestro market context Trend signal active 52 weeks +22.5% · Next-week setup positive 61.2%

13:07 25 Jul 2026

AD HOC NEWS Deals and strategy Main company 🇺🇸 United States

AbbVie stock trades steadily as Humira erosion meets Skyrizi and Rinvoq growth

AbbVie Inc. is managing a transition as its blockbuster drug Humira faces declining sales due to biosimilar competition. The company is actively offsetting this revenue loss with the strong growth of newer immunology drugs, Skyrizi and Rinvoq, which are showing double-digit percentage growth. Investors …

ABBV main company

Sharemaestro market context Trend signal active 52 weeks +21.3% · Next-week setup positive 57.6%

11:37 25 Jul 2026

Trefis Market update Main company 🇺🇸 United States

Should You Pay Attention To AbbVie Stock's Momentum?

The article poses a question about whether investors should pay attention to AbbVie stock's momentum. However, the provided content is largely navigational, legal disclaimers, and technical limitations of an interactive model, without any actual article text or financial analysis regarding AbbVie. It does not …

ABBV main company

Sharemaestro market context Trend signal active 52 weeks +21.3% · Next-week setup positive 57.6%

10:41 25 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Scilex Holding Company Revenue Breakdown – DUS:D8B0

This article provides a revenue breakdown for Scilex Holding Company (DUS:D8B0), highlighting that the United States was the primary contributor to its revenue in both the last year and the year prior. The revenue figures are presented in Euros.

SCLX main company

Sharemaestro market context Trend signal active 52 weeks -42.5% · Next-week setup negative 43.9%

09:40 25 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

GRFS|Grifols SA|Price:7.580|Chg%:+0.040

Grifols SA (GRFS) is a Spain-based global specialty pharmaceutical company with high growth potential, stable fundamentals, and a stock currently considered fairly valued. Despite an average stock market performance recently, the company's revenue and net income have seen significant growth, and institutional ownership remains …

GRFS main company

Sharemaestro market context Price below Trend Line 52 weeks -23.4%

08:59 25 Jul 2026

Market source Earnings Main company 🇺🇸 United States

Jim Cramer Said To Buy Johnson & Johnson (NYSE:JNJ)’s Shares – Here’s What Happened Next

Jim Cramer recommended buying Johnson & Johnson (NYSE:JNJ) shares, calling the dip in early July "a great level to start a position in a high-quality drug company" due to its divestment of consumer businesses making it a pure-play pharma company. Since his remarks, JNJ's …

JNJ main company

Sharemaestro market context Trend signal active 52 weeks +48.8%

08:40 25 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Dimensional Fund Advisors LP Increases Stock Position in Biogen Inc. $BIIB

Dimensional Fund Advisors LP significantly increased its stake in Biogen Inc. by 12.3% during the first quarter, adding 118,474 shares to reach a total of 1,079,119 shares valued at $197.9 million. This increase is part of a broader trend of institutional investors growing their …

BIIB main company

Sharemaestro market context Trend signal active 52 weeks +50.6% · Next-week setup positive 55.3%

08:07 25 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

AbbVie stock may move 4.2% on July 31 earnings report

AbbVie Inc. (NYSE:ABBV) stock is projected to move by 4.2% based on options data ahead of its July 31 earnings release. Historically, the stock's actual movement has often exceeded the implied move from options. The article details past earnings announcement performances, noting instances where …

ABBV main company

Sharemaestro market context Trend signal active 52 weeks +21.3% · Next-week setup positive 57.6%